Background: To assess the efficacy of pars plana vitrectomy (PPV) in management of tractional diabetic macular edema (DME) and highlight the benefits of additional internal limiting membrane (ILM) peeling. Methods: This an open-label, prospective, comparative and interventional study that enrolled 50 eyes with tractional DME that underwent PPV were split into two groups: group (A) consisted of 25 eyes that did not have ILM peeling, and group (B) consisted of 25 eyes that did. One, three, and six months after surgery, a postoperative assessment was completed. Results: Mean best corrected visual acuity (BCVA) in group (A) has improved from (0.89 the logarithm of minimal angle of resolution [LogMAR]) preoperatively to (0.64 LogMAR, p <0.001), and mean central macular thickness (CMT) declined from (471.28μm) to (228.20μm, p <0.001) after six months of PPV. In group (B), mean BCVA has improved from (0.83 LogMAR) preoperatively to (0.58 LogMAR, p <0.001), and mean CMT decreased from (496.84μm) to (226.20μm, p <0.001) after six months of PPV. There were no significant differences between the two groups after 1, 3, and 6 months according to the delta change % of BCVA and CMT. A significant negative correlation was detected between preoperative glycosylated hemoglobin (HbA1c) and BCVA improvement. Conclusions: PPV surgery is an effective treatment of tractional DME. Additional ILM peeling is not accompanied by extra benefits in a short period. Long-term glycemic control plays a role in vision gain after vitrectomy in diabetic patients.
Background To assess the efficacy of pars plana vitrectomy (PPV) in management of tractional diabetic macular edema (DME) and highlight the benefits of additional internal limiting membrane (ILM) peeling. Methods This prospective study involved 50 eyes with tractional DME that underwent PPV were split into two groups: group (A) consisted of 25 eyes that did not have ILM peeling, and group (B) consisted of 25 eyes that did. One, three, and six months after surgery, a postoperative assessment was completed. Results Mean best corrected visual acuity (BCVA) in group (A) has improved from (0.89 the logarithm of minimal angle of resolution [LogMAR]) preoperatively to (0.64 LogMAR, p < 0.001), and mean central macular thickness (CMT) declined from (471.28µm) to (228.20µm, p < 0.001) after six months of PPV. In group (B), mean BCVA has improved from (0.83 LogMAR) preoperatively to (0.58 LogMAR, p < 0.001), and mean CMT decreased from (496.84µm) to (226.20µm, p < 0.001) after six months of PPV. There were no significant differences between the two groups after 1, 3, and 6 months according to the delta change % of BCVA and CMT. A significant negative correlation was detected between preoperative glycosylated hemoglobin (HbA1c) and BCVA improvement. Conclusions PPV surgery is an effective treatment of tractional DME. Additional ILM peeling is not accompanied by extra benefits in a short period. Long-term glycemic control plays a role in vision gain after vitrectomy in diabetic patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.